Work

Use of Enterally Delivered Angiotensin II Type Ia Receptor Antagonists to Reduce the Severity of Colitis

Year: 2011

Type: article

Source: Digestive Diseases and Sciences

DOI: 10.1007/s10620-011-1651-9

Authors: Manabu Okawada, Hiroyuki Koga, Scott D. Larsen, Hollis D. Showalter, Anjanette J. Turbiak, Xiaohong Jin, Peter C. Lucas, Elke Lipka, John Hillfinger, Jae Seung Kim, Daniel H. Teitelbaum

Institutions: University of Michigan, Michigan Medicine, C. S. Mott Children's Hospital, Therapeutics Systems Research Laboratories (United States)

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: University of Michigan, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources

Awards: GPCR Signaling Through a Novel NF-kB Pathway, TPN Induced Changes in Intraepithelial Lymphocytes, G4301023730, Michigan Institute for Clinical and Health Research (MICHR) (UL1), Development of orally delivered, non-absorbable AT1 receptor antagonists for infl, Novel signal pathway mediating Hypertension/Obesity-dependent Insulin Resistance

OpenAlex ID: W2094023251

FWCI: 0.399

Cites: 57

Cited by: 25

Related to: 10